J&J’s Imaavy wins label expansion; Two approvals in Japan

J&J’s Imaavy wins label expansion: The monoclonal antibody is now the first treatment approved specifically for warm autoimmune hemolytic anemia, a rare autoantibody disease that causes severe anemia and fatigue. Imaavy ...